When Can a Beneficiary Join or Change a Medicare Prescription Drug Plan (PDP)?
Medicare beneficiaries can join, switch, or drop coverage from a Medicare prescription drug plan (PDP) during the annual coordinated election period (AEP). For the contract year 2007, the AEP was from November 15 through December 31, 2006. This is an important date span to remember each year because, every year, the AEP for the following contract year will be from November 15 through December 31 of the previous year. The AEP is the only time when all individuals eligible for Medicare prescription drug coverage can join a Medicare PDP, add additional coverage, or leave a Medicare PDP or a portion of the coverage. A beneficiary may also switch PDPs during the same time period. For example, a beneficiary may decide to switch from one PDP to another PDP during the AEP. If an eligible beneficiary drops Medicare prescription drug coverage entirely or misses the enrollment deadline, that beneficiary may not be eligible to enroll in the Medicare prescription drug benefit until November 15 of the following year, which may cause the beneficiary to incur a penalty for late enrollment. 
How Does the Open Enrollment Period (OEP) Differ From the Annual Coordinated Election Period (AEP)?
The open enrollment period (OEP) takes place between January 1, 2007, and March 31, 2007, and is scheduled to occur during the same time period in subsequent years. 2 The OEP is the opportunity for beneficiaries to add or change enrollment in a Medicare Advantage (MA) plan. For example, a beneficiary already enrolled in a Medicare Advantage-Prescription Drug plan (MA-PD) may change enrollment to a different MA-PD plan or to the traditional Medicare plan with a PDP (Table 1) . The beneficiary cannot use the OEP to add or drop Medicare prescription drug coverage-any new enrollment or disenrollment in prescription drug coverage must occur during the AEP. Table 1 .
How Will Beneficiaries Know What Changes to Current Coverage Occur in 2007?
During October 2006, all beneficiaries received an annual notice of change (ANOC) from the plan in which they were enrolled, and ANOCs will be sent to beneficiaries each year. ANOCs include notice of the monthly premium amount cost-sharing requirements and a summary of the benefits provided by the plan, including the drug formulary. 4 
What If a Beneficiary Changes Plans and a Drug Is Not Included in the Formulary?
A beneficiary who changed prescription drug plans in the AEP period may find, upon refilling usual prescriptions, that the drugs are not on the formulary of the new plan. A transition period applies in 2007, as it did in 2006, during which the nonformulary drug is covered for the first 30 days supply even if the prescription is for a drug that is not on the new plan' s drug list (or is a step-therapy drug). This gives the beneficiary and the physician time to find another drug on the plan' s drug list that would work as well or time for the physician to request an exception due to any special medical needs. 5 In addition, those individuals who reside in an LTC setting are eligible for transition fills up to 90 days supply. 6 The same appeals process for exceptions exists in 2007 as did in 2006. 
What If a Formulary Brand Drug Becomes Available as a Generic Drug?
If a plan changes the formulary status of a medication in the middle of a contract year, a beneficiary who had received the medication affected by the midyear formulary change can continue to receive the brand formulary medication for the same cost-share amount for the remainder of the contract year. For example, if a generic version of a single-source medication is released to the pharmaceutical market midyear and a plan adds the generic version to the formulary at tier-1 copayment and moves the original version of the drug, now a multiplesource brand drug, to tier-3 copayment from tier-2 copayment, the beneficiary who had received the brand medication in the contract year would be permitted to continue to receive the drug at the tier-2 cost-share amount for the remainder of the contract year. Beneficiaries who have incurred the late-enrollment penalty are most affected by the decrease in the national average base premium because the penalty amount is based on the national average Part D base beneficiary premium. "The lateenrollment penalty amount is at least 1% of the "base beneficiary premium" (the national average premium) for each full uncovered month that someone was eligible to but did not join a Medicare prescription drug plan." 8 For example, if a beneficiary must pay a 7% penalty because the beneficiary missed the May deadline for enrollment in 2006, the beneficiary will pay a penalty of $27.35 X 0.07 = $1.91/month in addition to their normal monthly premium. Pharmacists need to be aware that the penalty is based on the national average premium, not the premium of the beneficiary, and affected beneficiaries will always pay the penalty but the penalty amount will change from year to year as the national average premium changes each year. 8 
Will the Standard Benefit Change in 2007?
Changes will occur in the standard benefit (defined as the standard deductible, initial coverage limit, no coverage ["donut hole"], catastrophic coverage threshold, and other related factors) which is required to be updated every year by CMS as directed in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. 10 These changes are outlined in Table 2 . In fact, most beneficiaries do not have the standard coverage because beneficiaries can enroll in a plan with enhanced coverage that may charge a higher premium. Many beneficiaries have plans that require no deductibles or include coverage for drugs that are not Part D-covered drugs, such as benzodiazepines or barbiturates. For 2007, beneficiaries may enroll in plans offering enhanced coverage that includes ED drugs. Individuals who qualify for certain levels of extra help will not be affected by the changes to the standard benefit because they qualify for premium assistance provided by the federal government.
If a beneficiary enrolls in a plan with the standard coverage, the deductible will increase to $265 and the initial coverage limit will increase to $2,400. The true out-of-pocket (TrOOP) threshold will increase to $3,850, thereby creating a coverage gap between $2,400 and $5,451 in CY 2007. 11 TrOOP costs are defined by CMS as "the expenses that count toward the annual Medicare drug plan threshold for the year. These annual expenses determine the start of a beneficiary's catastrophic coverage. The drug plan will keep track of each person' s TrOOP costs. For every month that a beneficiary buys covered prescriptions, an explanation of benefits will be mailed that shows the beneficiary' s TrOOP costs to date." If the complaint refers to the drug formulary of a prescription drug plan, the appeals process is the first option. Once the plan renders a decision through the appeals process, the complaint process is the second step if the beneficiary believes that the plan has not acted in accordance with the policy of the Medicare Drug Benefit. ; the coverage exclusion for ED drugs does not apply, however, when prescribed for a U.S. Food and Drug Administration-approved indication other than ED, such as pulmonary hypertension. Also a beneficiary may be enrolled in an enhanced coverage plan that extends coverage for certain drugs that are not mandated to be covered by law, such as ED drugs for ED. Additional information on Part D drug coverage was issued in February 2006. This important guidance can be located on the CMS Web site at Part D Drugs/Part D Excluded Drugs (Table 3) . CMS issued guidance for the coverage of syringes used to administer insulin in the LTC setting versus coverage of syringes used to administer other drugs covered by the Medicare prescription drug benefit. CMS went on to define insulin syringes equipped with a safe needle device as Part D drugs. "Syringes, when used for the administration of insulin, meet the definition of Part D drugs. Preexisting 2006 regulations from the Occupational Safety & Health Administration require employers whose employees are exposed to self-injected needles, such as in nursing homes, to provide 'safe needle devices.' We view the sharps injury prevention feature involved with these specific types of syringes as 'special packaging' required for the administration of insulin in LTC facilities." "Part D sponsors are required to contract with LTC pharmacies that provide safe needle devices (and who meet all other applicable minimum performance and service criteria), and we expect the availability of these safety-capable syringes to be incorporated into the Part D sponsor' s standard network contract. As a reminder, payment to LTC pharmacies under Part D may only cover drug ingredient costs and dispensing fees as defined in the final regulations. These safe needle devices would be legitimate costs reflected in the dispensing fee. "This does not extend Part D reimbursement to any other types of syringes used in the administration of other Part D drugs in the LTC facility." 20 "While we continue to maintain that the syringes, associated with the administration of insulin dispensed in the long-term care setting, must maintain a safety device, based upon comments from the public, we believe these are better described in accordance with 1860D-2(e) of the Act, which defines 'medical supplies associated with the injection of insulin' as covered Part D drugs. Therefore, we are correcting our previous Q&A to define insulin syringes equipped with a safe needle device, in their entirety (syringe and device), as Part D drugs and subsequently they should be managed like any other Part D drug the plan places on their formulary." 21 LTC pharmacies may continue to seek Part D coverage for the appropriate insulin syringes used in administering insulin to patients residing in LTC facilities. Pharmacies that supply services to nursing homes, hospices, and home health services must follow the appropriate guidance for the appropriate setting.
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Under What Circumstances Can Beneficiaries Return or Donate Unused Medications?
CMS issued guidance for the handling of Part D-covered unused medications, which may commonly occur in the LTC setting. "If a beneficiary, typically residing in a nursing home, finds that they have an unused prescription medication, paid for by the Medicare prescription drug benefit, they can donate this medication, to the extent allowable under federal and state law and regulation, to state agencies and charitable organizations. Once the beneficiary has taken possession of, and insurance has paid for, the medication, the beneficiary is the owner of such medication and can dispose of the medication as they deem necessary. In certain circumstances, specially packaged unused drugs could be returned to long-term care pharmacies (LTCPs) and resold, provided such returns and resales are consistent with provisions of federal and state law. However, LTCP administrative costs to inspect, document, reverse claims, reimburse any beneficiary cost sharing, and reinventory of any such returned medications cannot be included in either the Part D ingredient cost or a corresponding dispensing fee. Consequently, these associated restocking fees cannot be billed as Part D drug costs. Further, while facilitating returns is discretionary, for those plans and pharmacies that process returns for resale, they must adjust the prescription drug expense and TrOOP accordingly" 21 In order to adjust the prescription drug expense and TrOOP expenses, a plan must follow the current policies of the plan that are based on the guidance issued by CMS for that contract year.
What Is the NPI and Why Do I Need One? "The NPI is the first opportunity for pharmacists to have an individual provider number with which to bill third parties. This includes billing PDPs for medication therapy management services (MTMS) under the Medicare Part D drug benefit. Pharmacists are encouraged to obtain an individual NPI. This is a new opportunity for pharmacists. Use of an NPI number is a requirement for but does not guarantee Medicare reimbursement." 22 There are 3 ways to obtain an NPI: (1) complete the application online, which can be found at https://NPPES.cms.hhs.gov/NPPES/Welcome.do; (2) download the paper application at www.cms.hhs.gov/NationalProvIdentStand/ and mail the application to the address on the form; or (3) after asking the provider's permission, an employer or other trusted organization may obtain an NPI for the provider by bulk enumeration, or electronic file interchange (EFI).
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Did You Know That Medicare Covers All of the Preventive Services Listed Below?
Pharmacists are the health care providers most accessible to Medicare beneficiaries and are in a key position to inform beneficiaries about the new preventive services that are covered by Medicare. For example, a beneficiary is eligible for a "Welcome to Medicare" medical office visit that includes a comprehensive physical examination during the first 6 months that a beneficiary first becomes eligible for Medicare Part B. The entry physical examination is the gateway to the Medicare health system and an opportunity for an individual to be diagnosed and receive care before the disease state has advanced and requires more care. The early diagnosis is beneficial to the individual because the beneficiary receives earlier care, resulting in better outcomes.
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When beneficiaries see their physician for the "Welcome to Medicare" physical examination, they should receive any needed referrals for other preventive services or treatment to be covered by Medicare. Beneficiaries need to utilize this benefit within the first 6 months of enrollment in Medicare Part B if their Medicare coverage begins on or after January 1, 2005. 24 A beneficiary may also receive other preventive services such as • influenza, pneumococcal or hepatits B vaccination; • mammography screening and Pap test and pelvic examination; • screening for colorectal cancer, prostate cancer, cardiovascular disease, diabetes, glaucoma; • bone-mass measurement; • diabetes self-management, supplies, and services; • medical nutrition therapy; and • smoking cessation. 25 Many health care professionals may not be aware of these benefits available to Medicare beneficiaries, and CMS has been working to promote awareness of the available preventive services. "CMS recognizes the crucial role that health care professionals play in promoting, providing, and educating Medicare patients about these potentially life-saving preventive services and screenings. Because of this understanding, we are taking significant steps to reach out and educate the provider community as well as Medicare beneficiaries about the array of preventive services and screenings covered by Medicare. However, we need your help to get the word out to your Medicare patients and their caregivers about the many preventive services and screenings covered by Medicare." 25 Health care providers can find additional information and links to materials for educating patients at: http://www.cms.hhs.gov/MLNProducts/ 35_PreventiveServices.asp#TopOfPage on the CMS Web site. Tables 3 and 4. 
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